Natural Compounds as Regulators of the Cancer Cell Metabolism

Abstract

Even though altered metabolism is an “old” physiological mechanism, only recently its targeting became a therapeutically interesting strategy and by now it is considered an emerging hallmark of cancer. Nevertheless, a very poor number of compounds are under investigation as potential modulators of cell metabolism. Candidate agents should display selectivity of action towards cancer cells without side effects. This ideal favorable profile would perfectly overlap the requisites of new anticancer therapies and chemopreventive strategies as well. Nature represents a still largely unexplored source of bioactive molecules with a therapeutic potential. Many of these compounds have already been characterized for their multiple anticancer activities. Many of them are absorbed with the diet and therefore possess a known profile in terms of tolerability and bioavailability compared to newly synthetized chemical compounds. The discovery of important cross-talks between mediators of the most therapeutically targeted aberrancies in cancer (i.e., cell proliferation, survival, and migration) and the metabolic machinery allows to predict the possibility that many anticancer activities ascribed to a number of natural compounds may be due, in part, to their ability of modulating metabolic pathways. In this review, we attempt an overview of what is currently known about the potential of natural compounds as modulators of cancer cell metabolism.

Cysteine-Conjugated Metabolites of Ginger Components, Shogaols, Induce Apoptosis through Oxidative Stress-Mediated p53 Pathway in Human Colon Cancer Cells

“…34−38 Ginger has been comprehensively studied in recent years for its chemopreventive properties, particularly against colorectal cancer. 39−42 Our group and others have identified active constituents of ginger, with our most recent focus on shogaols, especially 6S.…”

Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells

“…There has been substantial research effort to investigate the use of natural products, with good safety profile, to inhibit cancer and many other diseases [6,7]. Fisetin (3,3′,4′,7-tetrahydroxy flavone) is a flavonol present in the diet at concentrations ranging from 2 to 160 μg/g, and at much higher concentrations as an ingredient in nutritional supplements.…”

Physalin B not only inhibits the ubiquitin-proteasome pathway but also induces incomplete autophagic response in human colon cancer cells in vitro

“…Natural bioactive molecules have also been presumed to be safer than synthesized chemical compounds [2] . Many of these compounds have been identified as potential anticancer agents [3][4][5][6][7][8][9][10] .…”